Sunshine Biopharma Expands Its Generics Portfolio In Canada
The Firm Reported A 67% YoY Gross Revenue Increase In Q2 2024
After adding nine generics to its portfolio, Sunshine Biopharma prepares for more launches in the next year to strengthen its presence in Canada.
